Ascentage Pharma Rings the Nasdaq Stock Market Opening Bell
Ascentage Pharma Group International (Nasdaq: AAPG), a global biopharmaceutical company engaged in discovering, developing and commercializing therapies to address global unmet medical needs primarily in hematological malignancies, visits the Nasdaq MarketSite in Times Square to celebrate the pricing of its IPO on Nasdaq.
In honor of the occasion, Dr. Dajun Yang, Co-founder, Chairman and CEO, rings the Opening Bell.